Biomark Diagnostics Inc.

CNSX:BUX Stock Report

Market Cap: CA$14.9m

Biomark Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:BUX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Nov 24BuyCA$220Guoyu HuangIndividual1,000CA$0.22
28 Nov 24BuyCA$460Rashid Ahmed BuxIndividual2,000CA$0.23
22 Nov 24BuyCA$1,155Rashid Ahmed BuxIndividual5,500CA$0.21
21 Nov 24BuyCA$900Guoyu HuangIndividual4,500CA$0.20
15 Nov 24BuyCA$240Rashid Ahmed BuxIndividual1,020CA$0.24
15 Nov 24BuyCA$470Guoyu HuangIndividual2,000CA$0.24
11 Nov 24BuyCA$1,388Guoyu HuangIndividual6,000CA$0.24
08 Nov 24BuyCA$1,932Rashid Ahmed BuxIndividual8,400CA$0.23
25 Oct 24BuyCA$940Guoyu HuangIndividual4,000CA$0.24
10 Oct 24BuyCA$735Guoyu HuangIndividual3,000CA$0.24
10 Sep 24BuyCA$125Rashid Ahmed BuxIndividual500CA$0.25
10 Sep 24BuyCA$250Guoyu HuangIndividual1,000CA$0.25
22 Aug 24BuyCA$3,200Rashid Ahmed BuxIndividual15,200CA$0.21
22 Aug 24BuyCA$645Guoyu HuangIndividual3,000CA$0.22
20 Aug 24BuyCA$44,000Guoyu HuangIndividual200,000CA$0.22
20 Aug 24SellCA$44,000Bux Investments Ltd.Company200,000CA$0.22
09 Aug 24BuyCA$1,139Guoyu HuangIndividual5,300CA$0.21
09 Aug 24BuyCA$1,724Rashid Ahmed BuxIndividual7,800CA$0.22
08 Aug 24BuyCA$270Guoyu HuangIndividual1,200CA$0.23
01 Aug 24BuyCA$288Rashid Ahmed BuxIndividual1,200CA$0.24
01 Aug 24BuyCA$490Guoyu HuangIndividual2,000CA$0.25
25 Jul 24BuyCA$1,100Guoyu HuangIndividual5,000CA$0.22
12 Jul 24BuyCA$1,505Rashid Ahmed BuxIndividual7,000CA$0.22
11 Jul 24BuyCA$1,290Guoyu HuangIndividual6,000CA$0.22
05 Jul 24BuyCA$408Rashid Ahmed BuxIndividual1,700CA$0.24
04 Jul 24BuyCA$360Guoyu HuangIndividual1,500CA$0.24
21 Jun 24BuyCA$168Rashid Ahmed BuxIndividual700CA$0.24
20 Jun 24BuyCA$360Guoyu HuangIndividual1,500CA$0.24
14 Jun 24BuyCA$480Guoyu HuangIndividual2,000CA$0.24
08 Jun 24BuyCA$920Guoyu HuangIndividual4,000CA$0.23
07 Jun 24BuyCA$561Rashid Ahmed BuxIndividual2,600CA$0.22
30 May 24BuyCA$2,244Guoyu HuangIndividual10,200CA$0.22
29 May 24BuyCA$220Rashid Ahmed BuxIndividual1,000CA$0.22
24 May 24BuyCA$225Guoyu HuangIndividual1,000CA$0.23
23 May 24BuyCA$956Rashid Ahmed BuxIndividual4,250CA$0.22
16 May 24BuyCA$2,928Rashid Ahmed BuxIndividual10,800CA$0.28
16 May 24BuyCA$1,100Guoyu HuangIndividual4,000CA$0.28
01 May 24BuyCA$431Rashid Ahmed BuxIndividual1,500CA$0.29
01 May 24BuyCA$575Guoyu HuangIndividual2,000CA$0.29
25 Apr 24BuyCA$240Rashid Ahmed BuxIndividual800CA$0.30
19 Apr 24BuyCA$223Rashid Ahmed BuxIndividual750CA$0.30
18 Apr 24BuyCA$2,809Guoyu HuangIndividual10,500CA$0.28
18 Apr 24BuyCA$3,780Rashid Ahmed BuxIndividual13,800CA$0.29
11 Apr 24BuyCA$1,113Rashid Ahmed BuxIndividual3,700CA$0.30
11 Apr 24BuyCA$1,400Guoyu HuangIndividual5,000CA$0.28
15 Mar 24BuyCA$330Rashid Ahmed BuxIndividual1,100CA$0.30
08 Mar 24BuyCA$450Guoyu HuangIndividual1,500CA$0.30
20 Feb 24BuyCA$155Rashid Ahmed BuxIndividual500CA$0.31
08 Feb 24BuyCA$468Rashid Ahmed BuxIndividual1,600CA$0.32
02 Feb 24BuyCA$285Rashid Ahmed BuxIndividual1,000CA$0.29
23 Jan 24BuyCA$202Rashid Ahmed BuxIndividual750CA$0.27

Insider Trading Volume

Insider Buying: BUX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BUX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,144,7826.76%
General Public39,077,78143%
Private Companies45,663,66650.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.1%
Biomark Technologies Inc
41,004,167CA$6.7m0%no data
5.32%
Guoyu Huang
4,830,712CA$790.0k4.78%no data
4.67%
Bux Investments Ltd.
4,247,411CA$694.6k0%no data
1.45%
Rashid Ahmed Bux
1,314,070CA$214.9k1.3%no data
0.45%
Grg Consulting Ltd.
412,088CA$67.4k-32.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 13:44
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biomark Diagnostics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution